Pro Share Advisors LLC Bio N Tech Se Transaction History
Pro Share Advisors LLC
- $48.7 Billion
- Q2 2025
A detailed history of Pro Share Advisors LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Pro Share Advisors LLC holds 3,730 shares of BNTX stock, worth $389,188. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,730
Previous 4,488
16.89%
Holding current value
$389,188
Previous $408,000
2.7%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding BNTX
# of Institutions
320Shares Held
40.9MCall Options Held
1.37MPut Options Held
1.52M-
Baillie Gifford & CO8.04MShares$839 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$441 Million1.88% of portfolio
-
Primecap Management CO Pasadena, CA4MShares$418 Million0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.6MShares$375 Million0.24% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$198 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25.3B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...